105 related articles for article (PubMed ID: 16979647)
21. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
[TBL] [Abstract][Full Text] [Related]
22. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2.
Kimura K; Cheng XW; Nakamura K; Inoue A; Hu L; Song H; Okumura K; Iguchi A; Murohara T; Kuzuya M
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1096-101. PubMed ID: 20738326
[TBL] [Abstract][Full Text] [Related]
24. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells.
Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH
Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297
[TBL] [Abstract][Full Text] [Related]
25. Silencing Matrix Metalloproteinases 9 and 2 Inhibits Human Retinal Microvascular Endothelial Cell Invasion and Migration.
Gu Y; Ke G; Wang L; Gu Q; Zhou E; He Q; Wang S
Ophthalmic Res; 2015; 55(2):70-5. PubMed ID: 26613577
[TBL] [Abstract][Full Text] [Related]
26. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
27. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.
Southgate KM; Mehta D; Izzat MB; Newby AC; Angelini GD
Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1640-9. PubMed ID: 10397681
[TBL] [Abstract][Full Text] [Related]
28. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
29. Secondhand smoking and matrix metalloproteinase-2 and -9 gene expression in saphenous veins of women nonsmokers.
Sun Y; Lin Z; Ding WJ; Shi Y; Zhu L; Wei Q; Wang C
Ann Thorac Surg; 2014 Aug; 98(2):556-62. PubMed ID: 24961841
[TBL] [Abstract][Full Text] [Related]
30. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients.
Madi HA; Riches K; Warburton P; O'Regan DJ; Turner NA; Porter KE
Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1307-17. PubMed ID: 19741193
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
[TBL] [Abstract][Full Text] [Related]
32. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
33. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
34. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model.
Corpataux JM; Naik J; Porter KE; London NJ
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):177-81. PubMed ID: 15649726
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and Functional Transformation in Smooth Muscle Cells Derived from a Superficial Thrombophlebitis-affected Vein Wall.
Li K; Yu G; Xu Y; Chu H; Zhong Y; Zhan H;
Ann Vasc Surg; 2022 Feb; 79():335-347. PubMed ID: 34648856
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
37. Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration.
von Offenberg Sweeney N; Cummins PM; Birney YA; Redmond EM; Cahill PA
Biochem Biophys Res Commun; 2004 Jul; 320(2):325-33. PubMed ID: 15219830
[TBL] [Abstract][Full Text] [Related]
38. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
[TBL] [Abstract][Full Text] [Related]
39. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
40. Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells.
Yang G; Li H; Tang G; Wu L; Zhao K; Cao Q; Xu C; Wang R
J Mol Cell Cardiol; 2012 Mar; 52(3):677-88. PubMed ID: 22200376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
